Hybio Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
If you work at Hybio Pharmaceutical Co Ltd and you wish to use your ESG rating, please contact us. The page contains a questions and answers table about Hybio Pharmaceutical Co Ltd. The report of Hybio Pharmaceutical Co Ltd was assembled by All Street Sevva using cutting edge artificial intelligence.
Hybio Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Hybio Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Hybio Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Hybio Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Hybio Pharmaceutical Co Ltd report the average age of the workforce?
Does Hybio Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Hybio Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Hybio Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Hybio Pharmaceutical Co Ltd offer flexible work?
Does Hybio Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Hybio Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Hybio Pharmaceutical Co Ltd conduct supply chain audits?
Does Hybio Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Hybio Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Hybio Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Hybio Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Hybio Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Hybio Pharmaceutical Co Ltd disclose water use targets?
Does Hybio Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Hybio Pharmaceutical Co Ltd have a product recall in the last two years?
Does Hybio Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Hybio Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Hybio Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Hybio Pharmaceutical Co Ltd disclose parental leave metrics?
Does Hybio Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Hybio Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Hybio Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Hybio Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Hybio Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Hybio Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Hybio Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Hybio Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Hybio Pharmaceutical Co Ltd disclose its waste policy?
Does Hybio Pharmaceutical Co Ltd report according to TCFD requirements?
Does Hybio Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Hybio Pharmaceutical Co Ltd disclose energy use targets?
Does Hybio Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Hybio Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Hybio Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory and dossier support, etc. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.